EUVIMEDEUVIMED entdecken
Crossref

Real world clinical experience of using Brainomix e-CTA software in a medium size acute National Health Service Trust

Fraser Merchant iD, James Choulerton, Richard James, Chun Lap Pang

British Journal of Radiology · 2025

DOI: 10.1093/bjr/tqaf019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Fraser Merchant und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal United Hospital, Combe Park, Bath, Avon, BA1 3NG, United Kingdom. Hauptthemen laut MEDLINE: Computed Tomography Angiography, Software, Artificial Intelligence, Cerebral Angiography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Artificial intelligence (AI) software including Brainomix “e-CTA” which detect large vessel occlusions (LVO) have clinical potential. We hypothesized that in real world use where prevalence is low, its clinical utility may be overstated.

Methods

In this single centre retrospective service evaluation project, data sent to Brainomix from a medium size acute National Health Service (NHS) Trust hospital between January 3, 2022 and January 3, 2023 was reviewed. 584 intracranial computed tomography angiogram (CTA) datasets were analysed for LVO by e-CTA. The e-CTA output and radiology report were compared to ground truth, defined by a consultant radiologist with fellowship neuroradiology training, with access to subsequent imaging and clinical notes. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated.

Results

Of 584 cases (45% female, mean age 70 ± 16 years), 9% (n = 50) had LVO. e-CTA had a sensitivity of 0.78 (95% CI 0.64-0.88), specificity of 0.93 (0.9-0.95), PPV of 0.5 (0.42-0.58), and NPV of 0.98 (0.96-0.99). e-CTA had an error rate of 9% (52/584). Erroneous cases were categorized into causes for error. Common causes for false positives included incorrect anatomy (21%, 8/39) and other pathology (13%, 5/39), with several uncategorizable cases (39%, 15/39). Common causes for false negatives included LVO within the terminal internal carotid artery (ICA) (55%, 6/11) and uncategorizable (18%, 2/11).

Conclusions

We demonstrated that PPV of e-CTA is poor in consecutive cases in a real-world NHS setting. We advocate for local validation of AI software prior to clinical use. Advances in knowledge Common AI errors were due to anatomical misidentification, presence of other pathology, and misidentifying LVO in the terminal ICA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computed Tomography AngiographySoftwareArtificial IntelligenceCerebral AngiographyHumansFemaleRetrospective StudiesMaleAgedSensitivity and SpecificityMiddle AgedState MedicineAged, 80 and overPredictive Value of Tests

Stichwörter der Autor:innen

artificial intelligencelarge vessel occlusion detection

Autor:innen und Institutionen

  • Royal United Hospital, Combe Park, Bath, Avon, BA1 3NG, United Kingdom.

ORCID-Profile: Fraser Merchant

Zitieren

APA

Merchant, F., Choulerton, J., James, R., & Pang, C. L. (2025). Real world clinical experience of using Brainomix e-CTA software in a medium size acute National Health Service Trust. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf019

Vancouver

Merchant F, Choulerton J, James R, Pang CL. Real world clinical experience of using Brainomix e-CTA software in a medium size acute National Health Service Trust. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf019

BibTeX
@article{Merchant2025,
  author = {Merchant, Fraser and Choulerton, James and James, Richard and Pang, Chun Lap},
  title = {Real world clinical experience of using Brainomix e-CTA software in a medium size acute National Health Service Trust},
  journal = {British Journal of Radiology},
  year = {2025},
  doi = {10.1093/bjr/tqaf019}
}
Kostenlos starten →